Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Human Cell|December 1, 1996
Gene therapy: targeting tumor cells for destructionS D Rabkin, T Mineta, S Miyatake, et al.Nature Medicine|September 1, 1995
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomasT Mineta, S D Rabkin, T Yazaki, et al.Journal of Neuro-Oncology|January 1, 1995
Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470T Yazaki, Y Takamiya, P C Costello, et al.Cancer Research|August 1, 1994
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutantT Mineta, S D Rabkin, R L MartuzaBrain Research. Molecular Brain Research|December 31, 1996
Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migrationT Yazaki, R L Martuza, S D RabkinCancer Gene Therapy|July 1, 1997
Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant gliomaS Miyatake, R L Martuza, S D RabkinJournal of Virology|July 1, 1997
Transcriptional targeting of herpes simplex virus for cell-specific replicationS Miyatake, A Iyer, R L Martuza, et al.Cancer Research|November 1, 1995
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1T Yazaki, H J Manz, S D Rabkin, et al.Journal of Virology|July 10, 1999
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primatesW D Hunter, R L Martuza, F Feigenbaum, et al.Molecular Pharmacology|August 1, 1996
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.Pageof 32